Taken together, we identify roles for human LACC1, and establish loss-of-function consequences for the LACC1 Val254 IBD risk variant, thereby resulting in decreased amplification of PRR-induced mtROS, signalling, cytokines and bacterial clearance. This evidence concerns the gene LACC1 and inflammatory bowel disease.